COVID-19: Vaccines and Therapeutics
The Health Resources and Services Administration released fact sheets in English and Spanish on patient rights and provider responsibilities regarding access to COVID-19 vaccines.
An independent Centers for Disease Control and Prevention advisory committee recommended immediate resumption of the administration of Johnson & Johnson’s COVID-19 vaccine in the U.S.
Sarasota Memorial created a video addressing misinformation about COVID-19 vaccines and fears that are preventing people from getting their shots.
In this AHA Advancing Health podcast, Sara Jumping Eagle, M.D., and Kaylee Merrell, R.N., of the Indian Health Service discuss the plan to reduce the disproportionate COVID-19 infection rates in Indigenous communities through vaccine distribution and an administration strategy with national and…
President Biden announced that the nation has administered its 200 millionth COVID-19 vaccine dose, a milestone reached earlier than projected when vaccines were first authorized for emergency use by the Food and Drug Administration.
As part of National Minority Health Month (April), AHA shares takeaways from a conversation with the Henry Ford Health System and Islamic Center of America about their collaboration to increase COVID-19 vaccinations in the Muslim community around Detroit.
The Accelerating COVID 19 Therapeutic Interventions and Vaccines (ACTIV) initiative will enroll up to 13,500 adults aged 30 and over in a Phase 3 clinical trial to evaluate whether certain drugs approved for other conditions safely and effectively treat mild-to-moderate COVID-19, the National…
Atrium Health worked with partners to roll out mass vaccination events, roving units and smaller vaccination events to reduce barriers to access.
The AHA and Black Coalition against COVID April 21 at 7 p.m. ET will host a town hall on enhancing the opportunities for rural health care providers, public health organizations and rural health advocates as they advance COVID-19 prevention guidance, vaccine acceptance and vaccine administration.
The Food and Drug Administration revoked the emergency use authorization that allowed for the investigational monoclonal antibody therapy bamlanivimab, when administered alone, to be used for the treatment of mild-to-moderate COVID-19 in adults and certain pediatric patients.